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ABSTRACT
“CLINICAL PROFILE AND OUTCOME IN PATIENTS WITH COMMUNITY ACQUIRED
PNEUMONIA.”
By
Dr. Hardik Manubhai Pipalia
Introduction - Community-acquired pneumonia (CAP) is one of the most common infectious
diseases addressed by clinicians and is an important cause of mortality and morbidity
worldwide. Pneumonia is one of the leading causes of death and morbidity, both in
developing and developed countries and is the commonest cause (10%) of hospitalization in
adult and children. Estimates of the incidence of community-acquired pneumonia range
from 4 million to 5 million cases per year, with about 25% requiring hospitalization.
Community-acquired pneumonia refers to pneumonia acquired outside of hospitals or
extended-care facilities. The objective of the project to study etiological profile, clinical and
radiological profile and hospital outcome, the applicability of PSI score for the outcome, the
outcome related to age, gender, and risk factors in patients with CAP.
Method – The data was primarily collected in the department of medicine who were
diagnosed as community acquired pneumonia at GCS medical college, Ahmedabad, India
during 2014 to 2015. It is a retrospective clinical observational study which includes 50 adult
patients with CAP at admission to the hospital. Detailed relevant history and clinical
examination were done according to predesign and pre-tested format. The patients were
classified according to PSI score classification. The collected data was analyzed and
compared with previous studies on same/similar topics. Statistical analysis like chi square
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test, mean, standard deviation of the mean, and Fischer exact test were done.
Result – In this study, 48% patients were with bacteriological pneumonia, and 38% were
H1N1 pneumonia. Among those patients, risk factors for CAP like upper respiratory tract
infection (24%), Lung pathology (14%), Smoking (24%), and Diabetes mellitus (14%) were
present and statistically significant(p<0.05). Also, a radiological profile like lobar pneumonia
was most common in bacterial pneumonia (75%), and bronchopneumonia was most
common in H1N1 pneumonia (52.6%) which found statistically significant (p<0.05) in the
research study. In this study, death had occurred in 8.33% bacterial pneumonia, and 36.8%
H1N1 pneumonia which was statistically significant as p value is <0.05 by chi square test. In
the present study, 50% patients in PSI class IV and class V died which was statistically
significant (p<0.05), 100% patients of class V and 87.5% patients of class IV developed
complications, and most common complication was respiratory failure (47.3%) in H1N1
pneumonia, and most common complication was pleural effusion (20.8%) in bacterial
pneumonia.
Conclusion – In present study, H1N1 is most common pathogen (38%) in CAP followed by
Streptococcus pneumonia (28%) and death due to CAP was higher in H1N1(36.8%) in
compare to bacterial cause (8.33%) because this study’s data was taken in September 2014
to September 2015 which was the time of H1N1 epidemic in that region of India. In the
present study, most common chest x ray finding was patchy consolidation followed by left
lower zone involvement and right lower zone involvement. PSI (pneumonia severity index)
score is used for determination of hospital admission and assess 30-days mortality. Clinical
trials demonstrate that routine use of the PSI score results in lower admission rates for a
class I and class II patients. Patients in class III could ideally be admitted to an observation
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unit until a further decision can be made. In the present study, mortality was 50% in class IV
and class V patients.

3|Page

CLINICAL PROFILE AND OUTCOME IN PATIENTS WITH COMMUNITY ACQUIRED PNEUMONIA
By
DR HARDIK MANUBHAI PIPALIA
MPH, GEORGIA STATE UNIVERSITY
MBBS, GUJARAT UNIVERSITY, GUJARAT, INDIA

A Thesis Submitted to the Graduate Faculty
of Georgia State University in Partial Fulfillment
of the
Requirements for the Degree
MASTER OF PUBLIC HEALTH

ATLANTA, GEORGIA
30303

4|Page

APPROVAL PAGE
CLINICAL PROFILE AND OUTCOME IN PATIENTS WITH COMMUNITY ACQUIRED PNEUMONIA
by
DR HARDIK MANUBHAI PIPALIA

Approved:

Dr Ike Okosun, MS, MPH, Ph.D., FTOS, FACE
Committee Chair

Dr. Ruiyan Luo, Ph.D., MS, BS
Committee Member

July 21, 2017
Date

5|Page

Author’s Statement Page

In presenting this thesis as a partial fulfillment of the requirements for an advanced
degree from Georgia State University, I agree that the Library of the University shall make it
available for inspection and circulation in accordance with its regulations governing
materials of this type. I agree that permission to quote from, to copy from, or to publish this
thesis may be granted by the author or, in his/her absence, by the professor under whose
direction it was written, or in his/her absence, by the Associate Dean, School of Public
Health. Such quoting, copying or publishing must be solely for scholarly purposes and will
not involve potential financial gain. It is understood that any copying from or publication of
this dissertation which involves potential financial gain will not be allowed without written
permission of the author.

Dr Hardik Mnaubhai Pipalia
Signature of Author

6|Page

TABLE OF CONTENTS
LIST OF TABLES……………………………………………………………………………………………………………….......8
1. INTRODUCTION.....................................................................................................................9
1.1 Background………………………………………………………………….……….......................................9
1.2 Gap and purpose of the study………………………………………………………………………………….10
1.3 Aims and Objectives………………………………………………………………………………………………..10
2. REVIEW OF THE LITERATURE..............................................................................................11
2.1 Epidemiology of CAP……………………………………………………………………………….......…………11
2.2 Summary of LiteratureReview………………………………………………………………………………….12
3. Manuscript …………………......................................................................................................14
3.1 Introduction……………………………………………………………………………………………………………..14
3.2 Material and Method…………………………………………………..…………………………………………..26
3.3 Observation and Results...............................................................................................28
3.4 Conclusion and Discussion............................................................................................31
Tables ……………………………………………………………………………………………………………………………….33
REFERENCES...........................................................................................................................37
Annexure 1 (Abbreviations) ………………………………………………………………………………………………43

7|Page

List of Tables
TABLE 1. INCIDENCE BY AGE GROUP IN PATIENTS WITH CAP
TABLE 2. CLASSIFICATION OF PATIENTS ACCORDING TO PSI SEVERITY SCORE
TABLE 3. PRESENTATION OF CLINICAL FEATURES ACCORDING TO AGE AND GENDER
TABLE 4. PRESENTATION OF RISK FACTOR IN CAP PATIENTS
TABLE 5. COMPARISON BETWEEN RISK FACTORS AND RADIOLOGICAL FINDINGS
TABLE 6. BACTERIAL VS H1N1 PNEUMONIA WITH VARIOUS RISK FACTORS
TABLE 7. ETIOLOGICAL CLASSIFICATION OF CAP PATIENTS
TABLE 7a. BACTERIAL VS H1N1 PNEUMONIA IN DIFFERENT AGE GROUP
TABLE 7b. MICROORGANISM IDENTIFIED IN CAP PATIENTS
TABLE 8. RADIOLOGICAL PROFILE IN BACTERIAL AND H1N1 PNEUMONIA
TABLE 9. SECONDARY OUTCOME OF CAP RELATED TO GENDER AND AGE
TABLE 9a. OUTCOME RELATED TO ETIOLOGY
TABLE 9b. OUTCOME RELATED TO PSI CLASS
TABLE 10. DIFFERENT COMPLICATION IN CAP PATIENT

8|Page

CHAPTER 1
INTRODUCTION
Background
Pneumonia is a disease known to humanity from antiquity. Pneumonia is an acute
inflammation of the pulmonary parenchyma that can be caused by various infective and
noninfective origins, presenting with physical and radiological features compatible with the
pulmonary consolidation of a part or parts of one or both lungs (Seaton, Seaton, Leitch, & Crofton,
2000).
Pneumonia signifies a pulmonary inflammatory process. The most significant and striking
feature of which is consolidation (Kasper et al., 2005). Community acquired pneumonia is an acute
illness acquired in the community with symptoms suggestive of LRTI. Together with the presence of
a chest radiograph of intra-pulmonary shadowing which is likely to be new and has no clear
alternative cause (Seaton, Seaton, Leitch, & Crofton, 2000). Pneumonia is one of the leading causes
of death and morbidity, both in developing and developed countries and is the commonest cause
(10%) of hospitalization in adult and children (Hall et al., 20011).
Increasingly newer microbiological agents some of which are well known and some are very
new pathogens has revolutionized the understanding of pneumonia, and this led to the extensive
use of modern antibiotics (J. Bartlett, 2000). In the late twentieth and twenty-first century, newer
microbial agents have emerged like - opportunistic lung infection in patients with HIV infection and
post organ transplant patients (J. Bartlett, 2000).

All these have led to the need for an

understanding of the immunological status of the individual. With the beginning of an antibiotic era,
the mortality rate leveled off and remained constant. This mortality rate is heavily weighted against
elderly. This predilection of pneumonia for elderly is not new and led William Osler in 1898 to
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describe as ‘friend of the aged' J. (G. Bartlett et al., 2000). The actual incidence of pneumonia
acquired in the community is unknown and undoubtedly primary care physicians treat many
pneumonia episodes as ‘lower respiratory tract infection’ or ‘bronchiolitis’ without recourse to chest
radiographs (Stocks, Turnidge, & Crockett, 2004).

Gap and Purpose of the study
Previously, H1N1 pandemic 2009 and post pandemic 2014 has led to a massive interest in
H1N1 pneumonia. However clinical profile and outcome in CAP from varied etiology in a various
group of patients remain under documented and requires comprehensive study. Several prospective
studies have shown that risk factors for community acquired pneumonia are COPD, diabetes
mellitus, renal insufficiency, congestive cardiac failure, coronary artery disease, malignancy, chronic
neurologic disease, chronic liver disease, alcoholism, and smoking (Shah, Giudice, Griesback, Morley,
& Vasoya, 2004). There is a lack of scientific research in our population about PSI score as the
prognostic score for outcome in CAP. This study attempts to use PSI score as prognostic markers for
in hospital outcome in CAP. The purpose of undertaking this study is to study clinical profile,
complication, and outcome in CAP of varied etiology.

AIMS AND OBJECTIVES
●

To study Etiological profile in CAP

●

To Study of clinical profile, radiological profile, in hospital outcome in CAP of different
etiology.

●

To study the outcome of CAP patients related to age and gender.

●

To study the applicability of PSI score for in hospital outcome in CAP.
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CHAPTER 2
REVIEW OF LITERATURE
Epidemiology of CAP
John G. Barlett and Linda M. Mundy studied that, “the elderly patients who constitute the
adult population group with highest attack rate for CAP & the group with the highest mortality due
to disease” (J. Bartlett, 2000). M. J. Fine and others concluded their study that, “the mortality for
patients hospitalized with CAP was high and was associated with characteristics of the cohort,
pneumonia etiology, and a variety of prognostic factors” (M. J. Fine et al., 1996, 1997). According to
the Bartlett JG et all, “In the United States, approximately 4 million cases of pneumonia occur each
year, accounting for 10 million physician visits, approximately 500,000 hospitalizations, and
approximately 45,000 deaths” (Bartlett, Breiman, Mandell, & File, 1998). While the mortality has
ranged from 2% to 30% among hospitalized patients, the average rate is approximately 14% (Bartlett
et al., 1998). According to Mandell LL, “Mortality is estimated to be less than 1% for patients who are
not hospitalized. The total estimated cost of treating CAP is $23 billion, with indirect costs (e.g.,
absence from work) accounting for a significant percentage of this amount” (Mandell, 1995). For
persons between the ages of 5-60 years, various studies have reported the incidence of CAP
between 100-500 per 100,000 population (Mandell, 1995). According to Houston MS, et al., “CAP
occurs more commonly in children younger than the age of 5 years and adults older than the age of
65 years. In 1987, Houston and colleagues retrospectively evaluated the incidence of pneumonia
(nursing home and community-associated) in elderly residents (> 65 years of age) in Homestead
County, Minneapolis, MN” (Millett, Quint, Smeeth, Daniel, & Thomas, 2013).
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Summary of Literature Review
This review discusses the predisposing factors, causative pathogens, pathogenesis, etiology, as well
as the diagnostic studies and antimicrobial management of this important infection.
Dey at al shown that the presence of certain factors in addition to old age like h/o smoking
presence of COPD, late presentation to hospital, systolic & diastolic hypotension, high blood urea,
low serum albumin and development of septic shock was associated with higher incidence of
complications and a poorer prognosis (Dey, Nagarkar, & Kumar, 1997).
Marrie and her team recently summarized the findings from nine such studies that
streptococcus pneumoniae was the most common pathogen, accounting for 9% to 55% of cases in
the various studies or 18% of the pooled data from all studies and streptococcus pneumoniae
remains the most important pathogen; however, emerging resistance of the organism to
antimicrobial agents has affected empirical treatment of CAP (Mandell, Marrie, Grossman, Chow, &
Hyland, 2000). Diagnostic evaluation of CAP is essential for the appropriate assessment of severity of
illness and establishment of the causative agent of the disease (Garibaldi, 1985). According to
Michael J. Fine et al., they found a prediction rule to identify low-risk patients with communityacquired pneumonia. This prediction rule may help physicians to make more rational decisions about
hospitalization with pneumonia (Michael J. Fine et al., 1997). According to T. Franquet, has shown
that when an infectious pulmonary process is suspected, knowledge of varied radiographic
manifestations will narrow the differential diagnosis, helping to direct additional diagnostic
measures, and serving an ideal tool for follow up examination (Franquet, 2001). Joshua P. Metlay,
Michael J. Fine have reviewed the test characteristics of the history, physical examination, and
laboratory findings, individually and in combination in the diagnosis Of CAP and predicted the shortterm risk of death from the infection and shown that the absence of vital sign abnormalities
substantially reduces the possibility of the infection (Joshua P. Metlay & Fine, 2003). Jose Vilar and
others revealed in their study that the role of the radiologist is to be decisive in their diagnosis and
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follow up. The CXR remains a basic tool for this purpose (Vilar, Domingo, Soto, & Cogollos, 2004).
Sanraj K. Basi and others have studied that 1/3rd of patients suspected having pneumonia and is
admitted to hospital did not have pneumonia, but had serious LRTI with substantial rates of
bacteremia and mortality. The absence of radiographic findings should not supersede clinical
judgment and empiric treatments in these patients (Basi, Marrie, Huang, & Majumdar, 2004). J. P.
Metlay and others concluded in their study that respiratory, and non-respiratory symptoms are less
commonly reported by older patients with pneumonia even after the control, increased comorbidity,
and illness severity in these older patients (J. P. Metlay, Schulz, et al., 1997). Larry G. Reimer and
Karen C. Carrol found that ‘maximum benefit from currently available tests can be derived by their
use in patients with clear clinical and radiographic evidence of pneumonia' (Reimer & Carroll, 1998).
Robert E. Siege and others have concluded in their study that adult patients hospitalized for
CAP who are not severely ill can be successfully treated with an abbreviated (2 day) course of iv
antibiotics and then switched over to oral therapy (Siegel et al., 1996). A longer course of iv therapy
prolongs hospital stay and cost, without improving the therapeutic cure rate (Siegel et al., 1996).
Roger G. et al. studied that ‘CAP’ is a common condition, which has a significant mortality. The
management is centered around assessment and correction of gas exchange and fluid balance
together with administration of appropriate antibiotics’ (Roger et al.,1998). Thomas M. File Jr.
reviewed important features and management issues of CAP that were particularly relevant to
immunocompetent adults considering new information about the cause, clinical course, diagnostic
testing, treatment, and prevention (File, 2003).
Thomas P. et al. studied that pneumonia is a frequent cause of hospitalization and death
among elderly patients, but the relationship between processes of care for pneumonia and
outcomes are uncertain, making quality improvement a challenge (Meehan, Fine, Krumholz, & et al.,
1997).
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CHAPTER 3
Introduction
HISTORICAL REVIEW
Community acquired pneumonia has been recognized as a common and potentially
lethal condition for nearly two centuries. The term pneumonia (peri pneumonia) was first
introduced by Hippocrates in fourth century BC at that time treatment included leeches,
couplings, and shapes applied to the chest wall together with emetics, tonics, and purges to the
inflammation away from the chest. Vigorous bloodletting was also popular, particularly in
Great Britain. The erroneous concepts of anatomy and physiology of lung, which prevailed up
to last century, hampered the real understanding of pneumonia although it was regarded as
some inflammation of the lung. Celsus and others accurately described the condition.
Morgagni (1682-1717) identified the clinical features of pneumonia- solidification of
lungs. Gallon Carl Rokintasky (1804-1875) was first to differentiate between lobar pneumonia
and bronchopneumonia. William Wood Gerhard (1809-1872) wrote interesting papers on
smallpox and pneumonia in children. In 1834 Laennec paved the way for a modern
understanding of lobar pneumonia by describing the three stages of consolidation,
pathologically. PITIUS RATTLE (CRACKLES) as a pathognomonic sign of the first stage of
pneumonia., and is still considered. William Macullum (1874) demonstrated pathological
features of pneumonia. In 1879, a Swiss Physician described seven causes of atypical
pneumonia after contact with tropical birds. In 1881, Pasteur and Sternberg demonstrated
pneumococcus from normal saliva. Towards the end of nineteenth-century causes of
pneumonia became a matter of hot debate. Friedlander (1881-1884) first found bacteria in the
lungs of fatal causes of pneumonia, using staining technologies perfected by his colleague gram
and isolated an organism called pnemoneikrococcus (Friedlander's bacilli) from 30-year-old
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man died of pneumonia.
Several years later, Frinkel and others identified serological types of pneumonia,
which eventually led to serum therapy. With the discovery of penicillin (1951) and other
antibiotics, the solution to pneumonia was apparently sought, and interest in pneumonia
waned. Then it was found that there were ‘atypical pneumonia,' which is less severe and did
not respond to penicillin therapy (e.g. Mycoplasma pneumonia-eaton agent, Coxiella BurnettiQ fever, chlamydia psittacocci-psittacosis). Later in 1957 by the immunofluorescent technique,
they demonstrated a species of mycoplasma in the bronchial epithelium. Next major event in
the history of pneumonia was the outbreak of legionnaires disease in Philadelphia in 1976.
With many advances in the discovery of microbiological etiology of pneumonia, and modern
antibiotics have revolutionized the understanding and treatment of pneumonia. In late 20th
century, newer microbiological agents (opportunistic infections) in immunosuppressed patients
have been increasingly recognized, and this led to the need for an understanding of the
immunological status of the individual with pneumonia.
The most recent event occurred in 1986, does chlamydia pneumonia cause
pneumonia. This species is different from psittacosis. Although the bacteriological diagnosis
and immunological status of the individual have explained the pathophysiology of pneumonia,
the radiological recognition continues to be the most valuable investigative tool for the
diagnosis of pneumonia. The radiological type of pneumonia does give a major clue regarding
etiology and clinical outcome of pneumonia. Hence this attempt, to define and establish
completely the clinical, bacteriological, and radiological profile of pneumonia acquired in the
community admitted in our hospitals.

Community Acquired Pneumonia (CAP)
CAP is a common condition, which is caused by a variety of microbial pathogens with
differing antibiotic sensitivities. It presents as a spectrum of disease ranging from a simple febrile
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respiratory infection to a severe and fulminating illness leading to death (Finch & Woodhead, 1998).
An acute illness acquired in the community with symptoms suggestive of a lower respiratory tract
infection like Fever, cough, sputum-which may be purulent, chest pain, dyspnea together with the
presence on a chest radiograph of intrapulmonary shadowing which is likely to be new and has no
clear alternative cause like Lung cancer, pulmonary edema (Niederman et al., 2001).

Definition of CAP
A syndrome resulting from acute infection, usually bacterial, characterized by clinical and
radiographic signs of consolidation of a part or parts of one lung or both lungs (Niederman et al.,
2001).

Mode of transmission
Pathogens may enter the lung by following routes like Aspiration of organisms that colonize
the oropharynx, Inhalation of infectious aerosols, Hematogenous dissemination from an
extrapulmonary site, Direct inoculation and contiguous (adjoining) spread (Finch & Woodhead,
1998).

Pathology
The pneumonic process may involve the interstitial or alveoli primarily. The involvement of
an entire lobe is called-lobar pneumonia (Carroll, 2002). When the process is restricted to alveoli
adjoining to bronchi is called-bronchopneumonia (Carroll, 2002). Cavities develop when necrotized
lung tissue is discharged into communicating airways (Carroll, 2002). Pathogenesis of pneumonia
due to various microorganisms is same, but few differences or changes can be seen either in
pathology or subsequent complication(Carroll, 2002). According to Carroll and team, following is the
pathological staging for lung:
Pathological staging
●

Stage of congestion-fine crackles (INDUX CREPITUS)

●

Stage of red hepatisation-tubular bronchial breathing
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●

Stage of grey-hepatisation- tubular bronchial breathing

●

Stage of resolution-coarse crackles (REDUX CREPITUS)
The gross anatomic alteration may follow from the microscopic changes mentioned. Lobar

pneumonia may involve one lobe or several lobes, bilateral or unilateral (J. G. Bartlett et al., 2000).
Widespread involvement of all lobes is not common for the fact that the life can rarely be sustained
with such total impairment of lung function (J. G. Bartlett et al., 2000). Clinically one entire lobe is
involved, and inflammation is sharply limited to it by inter lobar fissure (J. G. Bartlett et al., 2000).
Pneumonia is predisposed by any condition that reduces or suppresses a cough, impairs mucociliary
activity, reduces the effective phagocytic activity of alveolar macrophages and neutrophils, impairs
immunoglobulin production (Bhatty, Pruett, Swiatlo, & Nanduri, 2011).

Etiology
According to Macfartane et al., Microbial pathogens that cause Community acquired pneumonia is
following: (Macfarlane, Ward, Finch, & Macrae, 1982)
A. Infective cause
Bacterial agents
•

Pneumococcal Pneumoniae

•

Staphylococcal Pneumoniae

•

Klebsiella Pneumoniae

•

Pseudomonas Pneumoniae

•

Escherichia Pneumoniae

•

Haemophilus Influenzae Pneumoniae

•

Moraxella Catarrhalis Pneumoniae

•

Legionella Pneumoniae

•

Mycoplasma Pneumoniae

•

Chlamydia Pneumoniae
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Viral agents
•

Influenza, Cytomegalovirus

•

Respiratory Synctial Virus

•

Measles

•

Hanta Virus
Other agents - Histoplasma, Coccidiodes, Blastomycoces, Parasitic Pneumonia
B. Non-Infective Cause - Lipid Physical Pneumonia, Radiation Pneumonia

Classification of pneumonia
According to Barlett et al., There are different classification based on studies which described below
(Barlett, Boitano, & Barman, 2010)
1.

Morbid anatomist’s classification
1.Lobar pneumonia
2.Segmental pneumonia
3.Sub segmental pneumonia
4.Bronchopneumonia

2.

Empiricist’s classification
1. Community acquired pneumonia
2. Hospital acquired pneumonia
3. Aspiration pneumonia
4. Immunocompromised pneumonia-aids related

3.

Microbiologist’s classification
1. Bacterial
2. Viral
3. Bacteria like and rickettsia like pneumonia
4. Fungal
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5. Parasitic pneumonia
6. Chemical pneumonia
7. Physical pneumonia-ionizing pneumonia
4.

Behaviorist’s classification
1. Easy pneumonia
2. Difficult pneumonia
The widely accepted classification of pneumonia is based on causative organism rather than

anatomic characteristics. There are many conditions, which can mimic non-resolving pneumonia.
They are Hypersensitivity pneumonitis, Drug induced pneumonitis, Sarcoidosis, Systemic necrotizing
vasculitis, Wagener’s granulomatosis, Pulmonary alveolar prognosis, Neoplastic disorder, and
Pulmonary embolism (Black, 2016). When a lung lesion diagnosed as pneumonia and fails to respond
to therapy or the resolution is inappropriately slow (failure of chest x-ray to clear within four weeks,
then the term non- resolving pneumonia come to play (Black, 2016). The presence of co- morbid
conditions such as CCF, systemic immunologic diseases, challenges the physician to speculate
whether these host factors are delaying resolution or to reconsider the diagnosis of pneumonia.
Furthermore, the severity of pneumonia and responsible pathogen may contribute to the overall
time required for complete resolution (Finch & Woodhead, 1998). Fein and Fein silver have defined
pneumonia to be non-resolving when a radiographic infiltrate has failed to resolve in appropriate
time course for the presumptive diagnosis after at least ten days of antibiotic therapy. Kirtland and
wlinterbaver described slowly resolving pneumonia as less than 50% clearing of radiographic
infiltrates at two weeks or less than complete clearing at four weeks in an immunocompetent
patient who has improved symptomatically.

Clinical manifestations
According to Sanraj Basi et al., CAP traditionally presents in two forms (Basi, Marrie, Huang, &
Majumdar, 2004):
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Typical - The typical pneumonia syndrome is characterized by sudden onset of fever
with or without chills, cough productive of purulent sputum, shortness of breath, pleuritic chest
pain, haemoptysis, and signs of pulmonary consolidation like dullness, increased vf/vr, egophony,
bronchial breath sounds and rales may be found on physical examination in chest x-ray. Most
common pathogen in CAP is Streptococcus Pneumoniae, but can also be due to H. influenzae and
mixed anaerobic and aerobic components of oral flora (Basi, Marrie, Huang, & Majumdar, 2004).
Atypical - The atypical pneumonia is characterized by gradual onset of fever, dry
cough, shortness of breath, a prominence of extrapulmonary symptoms-headache, myalgia, fatigue,
sore throat, nausea, vomiting, and diarrhea, with minimal signs on chest x-ray. Atypical pneumonia is
classically produced by M. pneumoniae, can also be caused by chlamydia pneumoniae, oral
anaerobes, and Pneumocystis carinii and less frequently encountered pathogens ch.psittaci, Coxiella
burnetii, Francisella tularensis, H. capsulatum, Coccidioides immitis, and certain viruses also produce
atypical pneumonia (Basi, Marrie, Huang, & Majumdar, 2004).
Non-respiratory symptoms of cap include lower lobe pneumonia may present with
abdominal pain, rigidity, ileus, marked confusion seen
may present with signs of

in patients

with

severe

pneumonia,

meningitis, cerebellar dysfunction, evidence of hypoxia, and

metabolic disturbances (Basi, Marrie, Huang, & Majumdar, 2004).

Diagnosis
The patient’s living circumstances, occupation, travel history, animal exposure history and contact
with patients will provide a clue to the microbial etiology of pneumonia (Joshua P. Metlay & Fine,
2003).
According to Joshua et al., Investigation required is following:
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A. Non-specific- Urine routine, Complete hemogram, Serologic studies-ELISA for HIV-1 and HIV-2,
Cardiac evaluation-ECG, Blood gas analysis, and Blood culture.
B. Specific
1. Non-invasive - CXR, Sputum examination – AFB and Gram stain, Sputum culture
2. Invasive – Bronchoscopy, Lung biopsy, and Pleural fluid examination
Microbiological investigation of patients admitted to the hospital with community acquired
pneumonia following flowchart (Woodhead, 1991)
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Treatment
CAP can be treated as Outpatient or In-Patient depending on the severity of CAP. An
empirical orally administered antimicrobial approach for mild pneumonia treated in CAP is below
described according to its category (Michael J. Fine et al., 1997).

Supportive treatment
The supportive treatment in CAP includes respiratory support given to the patients
who are in obvious respiratory distress with tachypnea and at a risk of dying due to hypoxia
and in need of close monitoring (Mandell, Marrie, Grossman, Chow, & Hyland, 2000). A PaO2
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of 6.7 kpa (50 mmHg) or less in the presence of a rising pco2 and acidosis are clear
indications that mechanical ventilation may be necessary. Also, Fluid and electrolyte
replacement gave to the patients with severe pneumonia because they may become
dehydrated and because of that their depleted intravascular volume requires parenteral
replacement (Mandell, Marrie, Grossman, Chow, & Hyland, 2000). Total parenteral nutrition
is best instituted early in cases of pneumonia in whom mechanical ventilation is likely to be
prolonged. Another consideration like the pleuritic pain is usually easily relieved by giving
simple non-sedative analgesics. Also, Physiotherapy may assist expectoration of sputum in
less ill patients (Mandell, Marrie, Grossman, Chow, & Hyland, 2000).

Complications
According to Mbata and his research team mentioned in their article, following are
the complications of CAP (Mbata, 2013)
Local

General

Delayed resolution and lung organization

Skin rashes

Spread to other lobes

Meningitis, peritonitis, septic

Lung-abscess - common in Klebsiellosis

Arthritis

Respiratory failure

Gastroenteritis

Pleural effusion, empyema, pneumothorax

Hemolytic anemia,
thrombocytopenia

Circulatory failure - Pericarditis, myocarditis

Factors associated with high mortality and requiring hospitalization
Many researchers found out that adverse prognostic indicators are old age, tachypnoea
(RR>30/min), hypotension (diastolic<60 mm hg), extensive involvement (>one lobe), atrial
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fibrillation, initial normal leukocyte count, persistent leukocytosis (> 20,000/pl), leucopenia
(<500/pl), and Hypoxemia help to check the severity of CAP (Michael J. Fine et al., 1997).
Following are the factors associated with high mortality and requiring hospitalization (Michael J.

Fine et al., 1997):
Clinical

Laboratory

Age> 60 years

TC < 4000 or > 20,000/cumm

RR > 30/min

Lymphocytes < 1000/cumm

HR>140/min

Urine output < 20 ml/day

BP < 90/60 mmHg

Chest x-ray biliary involvement

Altered sensorium

PaO2< 60mmHg

Immunocompromised state

Bacteremia

Differential diagnosis
There are many differential diagnoses like Pulmonary tuberculosis, Bronchiectasis, Lung
abscess, Liver abscess, and Hospital acquired pneumonia. Many studies concluded differences like
the route of infection, the infective organism, the mode of infection, the rate of mortality, and the
prevention modalities between CAP and Hospital acquired pneumonia (Niederman, McCombs,
Unger, Kumar, & Popovian, 1998).

Pneumonia severity index
According to Fine et al., “PSI is important prognostic factors in patients who are admitted to
the hospital. The pneumonia severity index (PSI) or PORT Score is a clinical prediction rule
that medical practitioners can use to calculate the probability of morbidity and mortality among
patients with community acquired pneumonia” (Fine et al., 1997). Community-acquired pneumonia
(CAP) is well known to be one of the leading causes of morbidity and mortality with a significant
financial burden (Marston et al., 1997). To manage the challenges of maintaining care quality while
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limiting treatment costs, many investigators have turned to the development of prognostic scores
(Ewig et al., 1998). The most widely accepted is the pneumonia severity index (PSI) developed by
Fine et al. (4), which uses a combination of age and clinical, laboratory and radiographic features to
estimate the mortality for an episode of CAP (Fine et al., 1997). Following is the PSI table and use
most of the time to diagnose the severity of CAP (Fine et al., 1997):

Step 1: Stratify to Risk Class I vs. Risk Classes II-V
Presence of:
Over 50 years of age

Yes/No

Altered mental status

Yes/No

Pulse ≥125/minute

Yes/No

Respiratory rate >30/minute

Yes/No

Systolic blood pressure <90 mm Hg

Yes/No

Temperature <35°C or ≥40°C

Yes/No

History of:
Neoplastic disease

Yes/No

Congestive heart failure

Yes/No

Cerebrovascular disease

Yes/No

Renal disease

Yes/No

Liver disease

Yes/No

If any "Yes," then proceed to Step 2
If all "No" then assign to Risk Class I
Step 2: Stratify to Risk Class II vs. III vs. IV vs. V
Demographics

Points
Assigned

If Male

+Age (yr)

If Female

+Age (yr) – 10

Nursing home resident

+10

Comorbidity
Neoplastic disease

+30
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Liver disease

+20

Congestive heart failure

+10

Cerebrovascular disease

+10

Renal disease

+10

Physical Exam Findings
Altered mental status

+20

Pulse ≥125/minute

+10

Respiratory rate >30/minute

+20

Systolic blood pressure <90 mm Hg

+20

Temperature <35°C or ≥40°C

+15

Lab and Radiographic Findings
Arterial pH <7.35

+30

Blood urea nitrogen ≥30 mg/dl
(9 mmol/liter)

+20

Sodium <130 mmol/liter

+20

Glucose ≥250 mg/dl (14 mmol/liter)

+10

Hematocrit <30%

+10

Partial pressure of arterial O2 <60mmHg

+10

Pleural effusion

+10

∑ <70 = Risk Class II
∑ 71-90 = Risk Class III
∑ 91-130 = Risk Class IV
∑ >130 = Risk Class V

MATERIALS AND METHODS
Study type: Retrospective clinical observational study
Study Period: September 2014 to September 2015
Source of data: Adult patients admitted to Department of Medicine who were diagnosed as
community acquired pneumonia at admission.
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Sample size: 50 patients
Inclusion Criteria:
● Age>12 years
● Clinical symptoms like fever, cough with or without expectoration, pleuritic chest
pain, dyspnea and altered sensorium.
● Clinical Signs like tachypnea, reduced chest movements, dull percussion note,
bronchial breath sounds, increased vocal fremitus and vocal resonance and
crepitation.
● Radiological evidence of pneumonia without any clinical evidence of pneumonia will
also be included
Exclusion criteria:
● Hospital acquired pneumonia
● Lung malignancy
● Aspiration pneumonia
● Pregnancy
● PLWHA, neutropenic patients
The method of Study: This is secondary data which was primarily collected in one of the
hospitals in India. During the study period, all patients presenting with and fulfilling the
inclusion criteria were included in this study. Detailed relevant history and clinical
examination were done according to predesigned and pretested format (Annexure-1). All
the patients were subjected to routine investigations like Complete blood count with ESR,
Routine biochemistry (RBS, RFT, LFT, Electrolyte), Sputum for Gram stain, AFB, Sputum
culture, Urine routine and microscopy, HIV, Chest X ray, Ultrasonography of Chest and
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Abdomen, and HbA1c. Also, other investigation as necessary such as H1N1, Pneumopanel,
Arterial blood gas analysis, and Blood culture.
The diagnosis is made in each of these cases was noted down. The patients were
classified according to PSI score classification. The patients were given a different group of
antibiotics according to their general condition and had given supportive treatment
according to their investigation. The primary outcome was defined as death. The secondary
outcome was identified as O2 support, NIMV/IMV, Complication, Absence from work < 10
days, and Absence from work > 10 days.
The collected data was analyzed and compared with previous studies on same/similar
topics. Statistical analysis wherever appropriate was applied. For the statistical analysis,
tests like Chi Square test, Mean, Standard Deviation of Mean, Fischer Exact test, and Odds
Ratio were used.

OBSERVATIONS AND RESULTS
In the present study, 50 patients of community acquired pneumonia were examined
with an objective to study etiological profile, clinical and radiological profile and hospital
outcome, the applicability of PSI score for the outcome, the outcome related to age, gender,
and risk factors. In this study, the incidence of CAP was more common in female (56%) as
compared to male (44%).The table 1 shows that the highest incidence of CAP was found in
the age group 41-50 years (30%) followed by 51-60 years (18%) then followed by 31-40
years. The Table 1 shows that age of 32 patients was below 50 years and age of 18 patients
was above 50 years that was not statistically significant as p value is >0.05. In table 2, 34%
patients have come under PSI class I, 28% patients have come under PSI class II, 18%
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patients have come under PSI class III, 16% patients have come under PSI class IV, 4%
patients have come under PSI class V. The table 3 shows that fever (94%) was the most
common symptom followed by a cough (84%), and hemoptysis (6%) was the least common
complaint by the participants. The table 3 shows that in young patients (age is <50 years)
cough (87.5%) was the most common clinical feature followed by fever (78.1%) and
breathlessness (71.8%) and among old patients (age is >50 years) fever (100%) was most
common clinical features followed by a cough (77.7%) and breathlessness (72.2%).
The table 4 shows that in male patients smoking (54%) was the most common risk
factor and in female patients preceding URTI (28.5%) was the most common risk factor.
Table 5 shows radiological findings in patients having different risk factors. In the present
study, lobar pneumonia was the most common in the patients having predisposing lung
pathology (85.7%), and bronchopneumonia was most common in diabetic patients (71.4%).
There was no statistical significance between risk factors (URTI, Smoker) for CAP and
radiological findings as p value is >0.05 as per chi square test. The table 6 shows that
bacterial pneumonia was occurred most commonly in patients having a risk factor of
smoking (83.4%), preceding lung pathology (85.7%), alcohol (80%) and for H1N1 pneumonia,
the most common risk factor was URTI (66.6%) followed by GERD (40%). Chi square test
was used for table 6 for URTI, DM, Lung pathology, and Smoking which shows there was
statistical significance as p value is <0.05.
The table 7 shows that 48% patients had bacteriological pneumonia, 38% patients
had H1N1 pneumonia, 4% patients have fungal pneumonia. The table 7a shows bacterial
pneumonia was more common in age < 50 years (66.6%) and H1N1 pneumonia was also
more common in age < 50 years (78.9%). However, as per chi square test, this association
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was not statistically significant as p value is >0.05. The table 7b shows that in 38% patients
had H1N1 positive, 28% patients had pneumococci positive, in 10% patients no organism
was identified. The table 8 shows that 75% patients with bacterial pneumonia had lobar
involvement in chest x ray and 52.6% of H1N1 pneumonia had lobular involvement in chest
x ray. The chi square test shows that this difference is statistically significant as p value is
<0.05. In the present study, lobar pneumonia (54%) was the most common radiological
feature on chest x ray. The table 9 indicates that 72.7% male and 75% female had required
O2 support, 22.7% male and 14.2% female have required NIMV/IMV, 59.1% male and 50%
female have developed a complication. This difference is not statistically significance as p
value is >0.05. These results show that 77.7% of patients of age >50 years had required O2
support, 33.3% of patients of >50 years had needed NIMV/IMV, 50% of patients with >50
years had developed a complication. There is no statistically significant difference among
above values as p value is >0.05. The table 9a shows that 66.6% bacterial pneumonia and
78.9% H1N1 pneumonia had required O2 support, 8.33% bacterial pneumonia and 26.3%
H1N1 pneumonia had required NIMV/IMV, 66.6% bacterial pneumonia and 57.8% H1N1
pneumonia had developed a complication. This observation is statistically not significant as
p value is >0.05. In this study, death had occurred in 8.33% bacterial pneumonia and 36.8%
H1N1 pneumonia. This is statistically significant as p value is <0.05 by chi square test. The
table 9b shows that 50% patients of class V had required O2 support and NIMV/IMV, 100%
patients of class IV, had required O2 support and 50% patients had required
NIMV/IMV,87.5% patients with class IV and 100% patients of class V had developed
complication, 50% patients with class IV and class V had expired. This observation is
statistically significant as p value is <0.05.
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The table 10 shows that pleural effusion had occurred in 20.8% bacterial pneumonia
and 5.26% H1N1 pneumonia. Respiratory failure had occurred in 12.5% bacterial pneumonia
and 47.3% H1N1 pneumonia. The observation from the table 10 has statistically significant
as p value is <0.05. The study shows that in expired male patients mean age is 57.75 years
and in female was 44.2 years. The patients those who were expired due to bacterial
pneumonia had mean age was 64 years and expired due to H1N1 pneumonia had mean age
was 46.28 years. The respiratory failure (77.7%) was the most common complication in
expired patients. Among expired patients’ bronchopneumonia was seen in 66.6% patients
and lobar pneumonia was observed in 33.3% patients on chest x ray. The DM (33.3%) was
the most common risk factors in expired patients.

CONCLUSION AND DISCUSSION
In the present study, it is found that H1N1 is a most common pathogen (38%) in CAP
followed by Streptococcus pneumoniae (28%). In the study of Larry G Reimer, others and
study of Sanraj K Basi Streptococcus were most common etiology. This study was done
between September 2014 to September 2015 duration. In this period H1N1 epidemic
occurred in our region. So, in this study H1N1 was the most common etiology in CAP
patients. In the present study, the most common presenting complaint was fever followed
by a cough followed by breathlessness. In Mac Fariene study, etiology and outcome of CAP,
a cough was a most common presenting complaint (92%) followed by fever (86%) and then
breathlessness (67%).
Chest film showing infiltrates necessary to establish the diagnosis of pneumonia.
Radiographic changes usually cannot be used to distinguish bacterial from nonbacterial
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pneumonia, but they are often important for evaluating the severity of illness, determining
the need for diagnostic studies and selecting an antibiotic agent. In the present study, most
common chest x ray finding was patchy consolidation followed by left lower zone
involvement and right lower zone involvement.
PSI (pneumonia severity index) score is used for determination of hospital admission
and assess 30-days mortality. Clinical trials demonstrate that routine use of the PSI score
results in lower admission rates for a class I and class II patients. Patients in class III could
ideally be admitted to an observation unit until a further decision can be made. In the
present study, mortality was 50% in class IV and class V patients.
PSI class

30-days mortality

Class I
Class II
Class III
Class IV
Class V

0.1%
0.6%
2.8%
8.2%
29.2%

In hospital mortality in
present study
7.14%
33.3%
50%
50%

Implication for further research
For the further study, more data will be needed to do and conclude the findings. This study only has
50 participation which is one of the limitations of the study as well. Also, PSI score implementation
for all patients who comes to the hospital with the clinical features of CAP which will give better data
about PSI applicability and significance of PSI with the outcome. Also, observe and create a database
on PSI score and respective treatment and then see what the outcome of the patients is. This
implementation and suggestion will give a better dataset to reach a statistically significant
conclusion about CAP.

Prevention and other important points to tackle CAP
Prevention of pneumonia involves either the decreasing likelihood of encountering
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pathogen or Strengthening the host’s response once the pathogen is encountered or
Immunization like Pneumococci vaccine. Also, early antibiotic administration within 4-6
hours, empiric antibiotic treatment as per guidelines (IDSA / ATS), PORT – PSI scoring and
Classification of cases, Early hospitalization in Class IV and V, Decrease smoking cessation advice / counseling, Arterial oxygenation assessment in the first 24 hours, Blood culture
collection in the first 24 h prior to another investigation, and Pneumococcal & Influenza
vaccination.

Results Tables
TABLE 1. INCIDENCE BY AGE GROUP IN PATIENTS WITH CAP
AGE (In years)

<50 Years

>50 Years

<21
21-30
31-40
41-50
51-60
61-70
>70
TOTAL
Mean Age + SD

MALE
No
1(4.5%)
2(9%)
2(9%)
7(31.8%)
3(13.6%)
5(22.7%)
2(9%)
22(56%)
52+18

FEMALE

12(40%)

10(16%)

No
1(3.6%)
5(17.8%)
6(21.4%)
8(28.6%)
6(21.4%)
2(7.1%)
0(0%)
28(44%)
43+13

TOTAL

20(24%)

8(20%)

No
2(4%)
7(14%)
8(16%)
15(30%)
9(18%)
7(14%)
2(4%)
50(100%)
47+16

TABLE 2. CLASSIFICATION OF PATIENTS ACCORDING TO PSI SEVERITY SCORE
CLASS
I
II
III
IV
V

MALE(n=22)
4(8.00%)
5(10.00%)
6(12.00%)
5(10.00%)
2(4.00%)

FEMALE(n=28)
13(26.00%)
9(18.00%)
3(6.00%)
3(6.00%)
0(0.00%)

TOTAL(n=50)
17(34%)
14(28%)
9(18%)
8(16%)
2(4%)
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TABLE 3. PRESENTATION OF CLINICAL FEATURES ACCORDING TO AGE AND GENDER
Clinical Features

Age

Gender

TOTAL(n=50)

<50 Years

>50 Years

Male(n=22)

Female(n=28)

No

Fever

29(90.6%)

18(100%)

21(95%)

26(92%)

47(94%)

Cough

28(87.5%)

14(77.7%)

20(90%)

22(78%)

42(84%)

Expectoration

13(40.6%)

9(50%)

11(50%)

11(39%)

22(44%)

Breathlessness

22(68.7%)

14(77.7%)

17(77%)

19(67%)

36(72%)

Pleuritic chest
pain

11(33.3%)

6(33.3%

7(31%)

10(35%)

17(34%)

Hemoptysis

1(3.1%)

2(11.1%)

2(9%)

1(3%)

3(6%)

Loss of weight

4(12.5%)

3(16.6%)

4(18%)

3(10%)

7(14%)

TABLE 4. PRESENTATION OF RISK FACTOR IN CAP PATIENTS
RISK FACTOR
Preceding URTI
DM
Alcohol
Lung pathology
CHF
Smoker
Immunosuppressed
TB
GERD

MALE(n=22)
4(18.1%)
2(9%)
5(22%)
7(32%)
2(9%)
12(54%)
2(9%)
1(4.5%)
1(4.5%)

FEMALE(n=28)
8(28.5%)
5(17.8%)
0
0
0
0
2(7.1%)
1(3.5%)
4(14.2%)

TOTAL(n=50)
12(24%)
7(14%)
5(10%)
7(14%)
2(4%)
12(24%)
4(8%)
2(4%)
5(10%)

TABLE 5. COMPARISON BETWEEN RISK FACTORS AND RADIOLOGICAL FINDINGS
CXR findings

URTI(n=12)

DM(n=7)

Lobar
involvement
Lobular
involvement

2(16.7%)

3(42.9%)

Lung
Smoker(n=12) GERD(n=5)
pathology(n=7)
4(57.1%)
3(25%)
2(40%)

10(83.3%)

4(57.1)

3(42.9%)

9(75%)

3(60%)
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TABLE 6. BACTERIAL VS H1N1 PNEUMONIA WITH VARIOUS RISK FACTORS
Different CAP

URTI
(n=12)

DM
(n=7)

Smoker
(n=12)

GERD
(n=5)

Alcohol
(n=5)

5(71.4%)

Lung
pathology
(n=7)
6(85.7%)

BACTERIAL
PNEUMONIA

4(33.3%)

10(83.4%)

3(60%)

4(80%)

H1N1 PNEUMONIA

8(66.7%)

2(28.6%)

1(14.3%)

2(16.6%)

2(40%)

1(20%)

TABLE 7. ETIOLOGICAL CLASSIFICATION OF CAP PATIENTS
Etiology
Bacteria
H1N1
Fungus
Unidentified

MALE(n=22)
13(59%)
7(31.8%)
0
2(9%)

FEMALE(n=28)
11(39.3%)
12(42.9%)
2(9%)
3(10.7%)

TOTAL(n=50)
24(48%)
19(38%)
2(4%)
5(10%)

TABLE 7a. BACTERIAL VS H1N1 PNEUMONIA IN DIFFERENT AGE GROUP
Age Group
Bacterial pneumonia(n=24) H1N1 pneumonia (n=19)
Age < 50 years
16 (66.6%)
15 (78.9%)
Age > 50 years
8 (33.3%)
4 (21.1%)
TABLE 7b. MICROORGANISM IDENTIFIED IN CAP PATIENTS
ORGANISM
NO OF PATIENTS(n=50)
PNEUMOCOCCI
14(28%)
STAPHYLOCOCCI
2(4%)
MYCOPLASMA
1(2%)
PSEUDOMONAS
2(4%)
KLEBSIELLA
1(2%)
AFB
4(8%)
H1N1
19(38%)
CANDIDA ALBICANS
2(4%)
UNKNOWN ETIOLOGY
5(10%)
TABLE 8. RADIOLOGICAL PROFILE IN BACTERIAL AND H1N1 PNEUMONIA
RADIOLOGICAL PROFILE

BACTERIAL PNEUMONIA
(n=24)

H1N1 PNEUMONIA
(n=19)

LOBAR PNEUMONIA

18(75%)

9(31.5%)

BRONCHOPNEUMONIA

4(16.6%)

10(52.6%)
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TABLE 9. SECONDARY OUTCOME OF CAP RELATED TO GENDER AND AGE
SECONDARY
OUTCOME
O2 SUPPORT
NIMV/IMV
COMPLICATION
ABSENCE FROM
WORK <10 DAYS
ABSENCE FROM
WORK >10 DAYS

MALE
(n=22)
17(77.2%)
5(22.7%)
13(59.1%)
10(45.5%)

FEMALE
(n=28)
21(75%)
4(14.2%)
14(50%)
23(82.1%)

Age < 50
Years(n=32)
24(75%)
3(9.3%)
18(75%)
23(71.8%)

Age > 50
years(n=18)
14(77.7%)
6(33.3%)
9(50%)
10(55.5%)

TOTAL(n=50
)
38(76%)
9(18%)
27(54%)
33(66%)

3(13.6%)

5(17.8%)

5(15.6%)

3(16.6%)

8(16%)

TABLE 9a. OUTCOME RELATED TO ETIOLOGY
OUTCOME

BACTERIAL
PNEUMONIA(n=24)
O2 SUPPORT
16(66.6%)
NIMV/IMV
2(8.33%)
COMPLICATION
16(66.6%)
ABSENCE FROM WORK <10 DAYS
19(79.1%)
ABSENCE FROM WORK >10 DAYS
3(12.5%)
DEATH
2(8.33%)
TABLE 9b. OUTCOME RELATED TO PSI CLASS
CLASS I
(n=17)
10(58.8%)
0
4(23.5%)
14(77.7%)

CLASS II
(n=14)
12(85.7%)
0
7(50%)
11(78.6%)

CLASS
III(n=9)
7(77.7%)
4(57.1%)
7(77.7%)
8(88.9%)

O2 SUPPORT
NIMV/IMV
COMPLICATION
ABSENCE FROM
WORK <10 DAYS
ABSENCE FROM
3(17.6%)
3(21.4%)
1(11.1%)
WORK >10 DAYS
DEATH
0
1(7.14%)
3(33.3%)
TABLE 10. DIFFERENT COMPLICATION IN CAP PATIENT
COMPLICATION
EMPYEMA
PLEURAL EFFUSION
SEPTIC SHOCK
SEPTIC AKI
RESPIRATORY
FAILURE
ARDS

H1N1
PNEUMONIA(n=19)
15(78.9%)
5(26.3%)
11(57.8%)
9(47.3%)
3(15.7%)
7(36.8%)
CLASS
IV(n=8)
8(100%)
4(50%)
7(87.5%)
7(87.5%)

CLASS V(n=2)

1(12.5%)

0

4(50%)

1(50%)

1(50%)
1(50%)
2(100%)
2(100%)

BACTERIAL
PNEUMONIA (n=24)
1(4.16%)
5(20.8%)
2(8.33%)
3(12.5%)

H1N1 PNEUMONIA
(n=19)
1(5.26%)
1(5.26%)
9(47.3%)

TOTAL(n=50)

-

1(5.26%)

1(2%)

1(2%)
8(16%)
3(6%)
1(2%)
13(26%)
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ANNEXURE I -ABBREVIATIONS
AFB – Acid fast bacilli
ARDS - Acute Respiratory Distress Syndrome
BBS - Bronchial breath sound
BP – Blood pressure
COPD- Chronic obstructive pulmonary disease
CAP - Community acquired pneumonia
CRP - C-reactive protein
CXR - Chest x-ray
CHF – Congestive heart failure
DM - Diabetes mellitus
ECG – Electrocardiogram
ESR – Erythrocyte sedimentation rate
ELISA - Enzyme linked immunosorbent assay
GERD - Gastro oesophageal reflux disease
HIV- Human immune deficiency virus
HR - Heart rate
ICU - Intensive care unit
IMV - Invasive mechanical ventilation
LFT – Liver function test
LRTI - Lower respiratory tract infection
NIMV - Non-invasive mechanic ventilation
PSI - Pneumonia severity index
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RBS – Random blood sugar
RFT- Renal function test
RR - Respiratory rate
TC - Total count
URTI - Upper respiratory tract infection
USG - Ultrasonography
WBC – White blood cells

ANNEXURE II – PROFORMA
PROFORMA
Irno.

Unit

Name

DOA

Age

DOD

Occupation
Address

CHIEF COMPLAINTS:
Present/Absent

Duration

Others

Fever
Cough
Expectoration
Breathlessness
Chest Pain
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Haemoptysis
Loss of Weight

PREDISPOSING FACTORS:
PRECEDING URTI

ALLERGY

DM

PAST PNEUMONIA

ALTERED SENSORIUM

ASTHMA

ALCOHOL

TB

COPD/ILD/BRONCHIACTASIS

GERD

CHF
SMOKER
IMMUNOCOMPROMISED

FAMILY HISTORY:
GENERAL EXAMINATION:
BUILT, NOURISHMENT, TEMPERATURE, PULSE, B.P., RESPIRATORY RATE, PALLER,
CYNOSIS, ICTERUS, CLUBBING, EDEMA, LYMPHADENOPATHY

SYSTEMIC EXAMINATION:
● RESPIRATORY SYSTEM:
S/O ConsolidationS/O EffusionS/O Obstructive Airway Disease● CARDIOVASCULAR:
● PER ABDOMEN:
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● CNS:

INVESTIGATIONS:
HB, TC, HCT, PLT, FBS, PPBS, CREATININE, UREA, SODIUM, POTTASIUM, SPUTUM,
GRAM STAIN, AFB, CULTURE, HBA1C, HIV, LFT, URINE, ALBUMIN, SUGAR,
MICROSCOPY, CXR, ECG, 2DECHO, PNEUMOPANEL, H1N1, USG, CSF

DIAGNOSIS:
ADMISSION:
ICU, WARD, Days of Absence from work

TREATMENT: ANTIBIOTICS
● Cephalosporin + Macrolide
● Anti –Pseudomonal regimen
● A + Fluoroquinolones
● Other

COMPLICATIONS:
Septic shock, Endocarditis, Septic Encephalopathy, Respiratory Failure, Pleural
effusion, Empyema

CHEST X RAY:
● LOBAR/BRONCHOPNEUMONIA
● UL/BL
● LATERAL VIEW

RESULT:
Survived/Expired
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